|
⚲
|
| Keyboard |
| OrbiMed Asia GP IV LP | |
|---|---|
| Firm | |
| Address | c/o OrbiMed Advisors LLC 601 Lexington Avenue, 54th Floor New York, NY 10022 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| OrbiMed Asia Partners IV LP | 021-362067 | Executive Officer | 486.9 M of 750.0 M |
||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kinnate Biopharma Inc KNTE
Common Stock
|
2024-04-03 | Disposed to issuer | 1,368,339 | ||
|
Kinnate Biopharma Inc KNTE
Common Stock
|
2024-04-03 | Disposed to issuer | 1,368,338 | ||
|
Kinnate Biopharma Inc KNTE
Common Stock
|
2024-04-03 | Disposed to issuer | 450,000 | ||
|
Kinnate Biopharma Inc KNTE
Common Stock
|
2024-04-03 | Disposed to issuer | 84,599 | ||
|
Kinnate Biopharma Inc KNTE
Common Stock
|
2024-04-03 | Disposed to issuer | 4,738,453 | ||
|
ArriVent BioPharma Inc AVBP
Common Stock
|
2024-01-30 | Conversion | 821,827 | ||
|
ArriVent BioPharma Inc AVBP
Common Stock
|
2024-01-30 | Conversion | 821,827 | ||
|
ArriVent BioPharma Inc AVBP
Common Stock
|
2024-01-30 | Conversion | 469,615 | ||
|
ArriVent BioPharma Inc AVBP
Common Stock
|
2024-01-30 | Conversion | 469,615 | ||
|
ArriVent BioPharma Inc AVBP
Common Stock
|
2024-01-30 | Buy | 222,222 | $18.00 | 3,999,996 |
|
ArriVent BioPharma Inc AVBP
Common Stock
|
2024-01-30 | Buy | 222,222 | $18.00 | 3,999,996 |
|
ArriVent BioPharma Inc AVBP
Series A Preferred Stock · derivative
|
2024-01-30 | Conversion | 821,827 | ||
|
ArriVent BioPharma Inc AVBP
Series A Preferred Stock · derivative
|
2024-01-30 | Conversion | 821,827 | ||
|
ArriVent BioPharma Inc AVBP
Series B Preferred Stock · derivative
|
2024-01-30 | Conversion | 469,615 | ||
|
ArriVent BioPharma Inc AVBP
Series B Preferred Stock · derivative
|
2024-01-30 | Conversion | 469,615 | ||
|
Kinnate Biopharma Inc KNTE
Common Stock
|
2023-05-05 | Buy | 490,511 | $2.82 | 1,383,241 |
|
Kinnate Biopharma Inc KNTE
Common Stock
|
2023-05-05 | Buy | 490,512 | $2.82 | 1,383,244 |
|
Kinnate Biopharma Inc KNTE
Common Stock
|
2023-05-04 | Buy | 312,991 | $2.75 | 860,725 |
|
Kinnate Biopharma Inc KNTE
Common Stock
|
2023-05-04 | Buy | 83,459 | $2.75 | 229,512 |
|
Kinnate Biopharma Inc KNTE
Common Stock
|
2023-05-04 | Buy | 83,459 | $2.75 | 229,512 |
| showing 20 of 31 most recent transactions | |||||